CLINICAL TRIALS
Biomobie Technology
[Evaluation of integrated wave micro-magnetic field therapeutic device using randomized blind, placebo-controlled, multi-center clinical trial to determine the safety and efficacy in the treatment of patients with chronic insomnia.]

The follow-up results of the integrated wave micro-magnetic field therapeutic device after listing showed that the integrated wave micro-magnetic field therapy device can improve sleep disorder while at the same time assisting blood-pressure reduction with an efficacy of 82.05%. In order to verify this effect, Biomobie conducted clinical trials of chronic insomnia at the Brigham and Women's Hospital affiliated with Harvard Medical School using the listed integrated wave micro-magnetic field therapeutic device. The integrated micro-magnetic device observably reduced insomnia and is suitable for use with a wide range of people. In order to expand the indications in China, Biomobie is conducting a multi-center clinical trial at Huaxi Hospital of Sichuan University and Tangdu Hospital of the Fourth Military Medical University to verify the efficacy of the integrated wave micro-magnetic field therapy device for chronic insomnia.

Huaxi Hospital is affiliated with Sichuan University.
Tangdu Hospital is affiliated with the Fourth Military Medical University.
2018年08月15日
Biomobie Corp., USA
Biomobie (Shanghai) Regenerative Medicine co., Ltd.
 

Scan qr code to share to WeChat